findmyKOL

Michael Kasperkiewicz

Basic profile

University of California, Los Angeles

ORCIDNone on fileNPI
RegionLos Angeles, CA · WestSpecialtyDermatologyFocusDermatology
Last active 2021findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Michael Kasperkiewicz is a Dermatology physician affiliated with University of California, Los Angeles. OpenAlex indexes 133 publications with 4,059 citations (h-index 33).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
133publications

Distinct works indexed by OpenAlex.

4,059citations

Total citations across indexed works.

33h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    36%
    Corticosteroid22.5%
    Triamcinolone Acetonide100%
    Part D39 patients
    Other antifungals for topical use8.7%
    Ciclopirox100%
    Part D<11 patients

    + 1 more class in this area

  • Sensory organs

    20.8%
    Corticosteroid20.8%
    Clobetasol Propionate68%Betamethasone Diprop Augmented32%
    Part D<11 patients
  • Anti-infectives

    17.3%
    Azole Antifungal13.5%
    Ketoconazole100%
    Part D24 patients
    Nitroimidazole Antimicrobial3.8%
    Metronidazole100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”